Annual CFF
$41.78 M
+$177.11 M+130.87%
December 31, 2022
Summary
- As of February 10, 2025, RVLP annual cash flow from financing activities is $41.78 million, with the most recent change of +$177.11 million (+130.87%) on December 31, 2022.
- During the last 3 years, RVLP annual CFF has risen by +$46.47 million (+990.71%).
Performance
RVLP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$460.00 K
+$4.40 M+90.53%
June 30, 2023
Summary
- As of February 10, 2025, RVLP quarterly cash flow from financing activities is -$460.00 thousand, with the most recent change of +$4.40 million (+90.53%) on June 30, 2023.
- Over the past year, RVLP quarterly CFF has increased by +$521.00 thousand (+53.11%).
Performance
RVLP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$38.28 M
+$521.00 K+1.38%
June 30, 2023
Summary
- As of February 10, 2025, RVLP TTM cash flow from financing activities is $38.28 million, with the most recent change of +$521.00 thousand (+1.38%) on June 30, 2023.
- Over the past year, RVLP TTM CFF has increased by +$169.63 million (+129.14%).
Performance
RVLP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RVLP Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +130.9% | +53.1% | +129.1% |
3 y3 years | +990.7% | +57.6% | +47.0% |
5 y5 years | +279.2% | +64.5% | +916.0% |
RVLP Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | -423.9% | -100.8% | +956.5% | -60.5% | -455.1% |
5 y | 5-year | at high | -423.9% | -100.8% | >+9999.0% | -60.5% | -609.3% |
alltime | all time | -90.1% | -423.9% | -100.8% | >+9999.0% | -60.5% | -609.3% |
RVL Pharmaceuticals Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$460.00 K(-90.5%) | $38.28 M(+1.4%) |
Mar 2023 | - | -$4.86 M(-448.1%) | $37.76 M(-9.6%) |
Dec 2022 | $41.78 M(-130.9%) | $1.40 M(-96.7%) | $41.78 M(-56.9%) |
Sep 2022 | - | $42.20 M(-4402.2%) | $96.95 M(-173.8%) |
Jun 2022 | - | -$981.00 K(+17.2%) | -$131.35 M(-3.4%) |
Mar 2022 | - | -$837.00 K(-101.5%) | -$135.93 M(+0.4%) |
Dec 2021 | -$135.33 M(-3775.4%) | $56.56 M(-130.4%) | -$135.33 M(-30.6%) |
Sep 2021 | - | -$186.10 M(+3247.7%) | -$194.97 M(+509.2%) |
Jun 2021 | - | -$5.56 M(+2255.5%) | -$32.00 M(+16.3%) |
Mar 2021 | - | -$236.00 K(-92.3%) | -$27.53 M(-847.7%) |
Dec 2020 | $3.68 M | -$3.08 M(-86.7%) | $3.68 M(-24.5%) |
Sep 2020 | - | -$23.13 M(+2032.0%) | $4.88 M(-81.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2020 | - | -$1.08 M(-103.5%) | $26.05 M(-4.6%) |
Mar 2020 | - | $30.98 M(-1748.5%) | $27.29 M(-681.8%) |
Dec 2019 | -$4.69 M(-230.2%) | -$1.88 M(-4.4%) | -$4.69 M(-171.9%) |
Sep 2019 | - | -$1.97 M(-1305.5%) | $6.53 M(+6.5%) |
Jun 2019 | - | $163.00 K(-116.1%) | $6.13 M(+31.2%) |
Mar 2019 | - | -$1.01 M(-110.8%) | $4.67 M(+29.6%) |
Dec 2018 | $3.60 M(-115.5%) | $9.34 M(-495.1%) | $3.60 M(-162.9%) |
Sep 2018 | - | -$2.36 M(+82.6%) | -$5.73 M(+70.1%) |
Jun 2018 | - | -$1.29 M(-37.6%) | -$3.37 M(+62.4%) |
Mar 2018 | - | -$2.08 M | -$2.08 M |
Dec 2017 | -$23.31 M(-105.5%) | - | - |
Dec 2016 | $420.52 M | - | - |
FAQ
- What is RVL Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual CFF year-on-year change?
- What is RVL Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly CFF year-on-year change?
- What is RVL Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals TTM CFF year-on-year change?
What is RVL Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of RVLP is $41.78 M
What is the all time high annual CFF for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual cash flow from financing activities is $420.52 M
What is RVL Pharmaceuticals annual CFF year-on-year change?
Over the past year, RVLP annual cash flow from financing activities has changed by +$177.11 M (+130.87%)
What is RVL Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of RVLP is -$460.00 K
What is the all time high quarterly CFF for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly cash flow from financing activities is $56.56 M
What is RVL Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, RVLP quarterly cash flow from financing activities has changed by +$521.00 K (+53.11%)
What is RVL Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of RVLP is $38.28 M
What is the all time high TTM CFF for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high TTM cash flow from financing activities is $96.95 M
What is RVL Pharmaceuticals TTM CFF year-on-year change?
Over the past year, RVLP TTM cash flow from financing activities has changed by +$169.63 M (+129.14%)